Dermatitis News

LOS ANGELES — Patients with chronic spontaneous urticarial who were evaluated by an allergist experienced a marked reduction in corticosteroid prescriptions, according to a recent study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Patients with primary Sjögren’s syndrome may have a high incidence of pruritus that may negatively impact sleep and quality of life, according to recently presented data.

WASHINGTON — In a video perspective on the eve of the American Academy of Dermatology Annual Meeting, Hillary Baldwin, MD, discusses a two-part study comparing Soolantra (ivermectin, Galderma) cream 1% with metronidazole 0.75% cream in treating patients with papulopustular rosacea.

Santalis Pharmaceuticals announced in a press release positive preliminary results from an expanded study of its Santalia AD product regimen for treating pediatric atopic dermatitis.

Research finding that a multifaceted sun protection program, including text message reminders and swim shirts, improved sun protection behaviors and helped to prevent skin damage in children was among developments recently reported on Healio.com/Dermatology.

Researchers have found that a mutation in the ADGRE2 protein may be responsible for patients developing vibratory urticaria in families with a history of the condition, according to recent research.

Patients with chronic spontaneous urticaria are unlikely to have a parasite infection as a common cause, according to results from a systematic review.

Eli Lilly and Company and Incyte Corp. announced in a press release that Lilly has submitted a new drug application to the FDA for its once-daily oral baricitinib as a treatment for moderate-to-severe rheumatoid arthritis.

Anti-programmed cell death-1 therapy for patients with metastatic melanoma was associated with cutaneous adverse events, including lichenoid reactions, eczema and vitiligo, according to recently published study results.

Factors such as eczema and wheeze appeared to increase the overall risk for atopic disorders in pediatric patients, according to study results published in World Allergy Organization Journal.